French multicentre prospective evaluation of radiofrequency ablation in the management of haemorrhoidal disease
- PMID: 37005961
- PMCID: PMC10485119
- DOI: 10.1007/s10151-023-02787-1
French multicentre prospective evaluation of radiofrequency ablation in the management of haemorrhoidal disease
Abstract
Purpose: The aim of this study was to evaluate the efficacy and safety of radiofrequency ablation (RFA) in the management of haemorrhoidal disease with 1 year's follow-up.
Method: This prospective multicentre study assessed RFA (Rafaelo©) in outpatients with grade II-III haemorrhoids. RFA was performed in the operating room under locoregional or general anaesthesia. Primary endpoint was the evolution of a quality-of-life score adapted to the haemorrhoid pathology (HEMO-FISS-QoL) 3 months after surgery. Secondary endpoints were evolution of symptoms (prolapsus, bleeding, pain, itching, anal discomfort), complications, postoperative pain and medical leave.
Results: A total of 129 patients (69% men, median age 49 years) were operated on in 16 French centres. Median HEMO-FISS-QoL score dropped significantly from 17.4/100 to 0/100 (p < 0.0001) at 3 months. At 3 months, the rate of patients reporting bleeding (21% vs. 84%, p < 0.001), prolapse (34% vs. 91.3%, p < 0.001) and anal discomfort (0/10 vs. 5/10, p < 0.0001) decreased significantly. Median medical leave was 4 days [1-14]. Postoperative pain was 4/10, 1/10, 0/10 and 0/10 at weeks 1, 2, 3 and 4. Seven patients (5.4%) were reoperated on by haemorrhoidectomy for relapse, and three for complications. Reported complications were haemorrhage (3), dysuria (3), abscess (2), anal fissure (1), external haemorrhoidal thrombosis (10), pain requiring morphine (11). Degree of satisfaction was high (+ 5 at 3 months on a - 5/+ 5 scale).
Conclusion: RFA is associated with an improvement in quality of life and symptoms with a good safety profile. As expected for minimally invasive surgery, postoperative pain is minor with short medical leave.
Clinical trial registration and date: Clinical trial NCT04229784 (18/01/2020).
Keywords: Haemorrhoids; Radiofrequency ablation; Rafaelo© procedure; Surgery.
© 2023. The Author(s).
Conflict of interest statement
Abramowitz Laurent, Laurain Anne and Dominique Bouchard are consultants for F Care. Aurelien Venara is consultant for Intuitive surgery, Sanofi Aventis, Takeda, Thermofisher. Guillaume Bonnaud is consultant for Abbvie, Alfasigma, Bouchara Recordatti, Celltrion, Ferring, Janssen, Gilead, Medtronic, MSD, Norgine, PFIZER, Roche, Takeda, Tillotts. The other authors declare that they have no conflict of interest.
Figures
References
-
- Milligan ETC, Naunton Morgan C, Jones LE, Officer R. Surgical anatomy of the anal canal, and the operative treatment of hæmorrhoids. Lancet. 1937;230(5959):1119–1124. doi: 10.1016/S0140-6736(00)88465-2. - DOI
Publication types
MeSH terms
Associated data
LinkOut - more resources
Full Text Sources
Medical
Research Materials
